Clinical Trial: Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting

U.S., Aug. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07124195) titled 'Nanocrystalline Megestrol for Managing Chemotherapy-Induced Nausea and Vomiting' on Aug. 02.

Brief Summary: The goal of this clinical trial is to learn if medroxyprogesterone acetate oral suspension (Meishiya(R)) works to prevent nausea and vomiting caused by single-day moderate to high emetogenic chemotherapy (MEC/HEC) in the whole-process management. It will also learn about the safety of medroxyprogesterone acetate oral suspension (Meishiya(R)). The main questions it aims to answer are:

Does medroxyprogesterone acetate oral suspension (Meishiya(R)) effectively prevent nausea and vomiting induced by single-day MEC/HEC in the whol...